(Q73837093)

English

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)

scientific article published on 01 May 2000

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

W E Boden

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

W H van Gilst

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R G Scheldewaert

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

I R Starkey

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M F Carlier

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D G Julian

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Whitehead

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M E Bertrand

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J J Col

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

O L Pedersen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K I Lie

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J P Santoni

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K M Fox

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

355

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

9217

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1751-1756

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Trial of early nifedipine in acute myocardial infarction: the Trent study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic correlates of reperfusion status after thrombolysis: is the "incomplete" or "interrupted" infarction a non-Q-wave infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evalu

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic and bioavailability of diltiazem sustained‐release: influence of food and time of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacological basis and pathophysiological significance of the heart rate-lowering property of diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902262-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02262-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10832825%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73837093&oldid=1760693177"